首页 | 本学科首页   官方微博 | 高级检索  
     

阿普唑仑可降低射频导管消融手术患者的住院费用
引用本文:Zhu YJ,Liu ZY,Chen Y,Zheng P,Zhu JH,Tao QM,Zheng LR,Wang QQ,Shi MJ,Qiu YG. 阿普唑仑可降低射频导管消融手术患者的住院费用[J]. 中华心血管病杂志, 2007, 35(10): 919-922
作者姓名:Zhu YJ  Liu ZY  Chen Y  Zheng P  Zhu JH  Tao QM  Zheng LR  Wang QQ  Shi MJ  Qiu YG
作者单位:1. 浙江大学医学院附属第一医院心内科,杭州,310003
2. 浙江医学高等专科学校图书信息中心
基金项目:浙江省科技攻关基金资助项目(2004C33025和2003C33008);浙江省教育厅基金资助项目(20020825)
摘    要:目的观察术前加用阿普唑仑对射频导管消融手术患者的心理状况及住院费用的影响。方法前瞻性、随机、双盲、安慰剂对照研究142例因阵发性室上性心动过速而择期行首次心内电生理检查或射频导管消融手术的患者,随机纳入安慰剂组(对照组,70例)或阿普唑仑组(治疗组,72例)。所有患者均于入组当晚开始每晚睡前服用阿普唑仑0.4mg或外形、性状类似于治疗药的安慰剂,至少3天后行射频导管消融治疗。所有患者均于术前24h内行中国版90项症状量表评价。结果二组之间年龄、性别、体重、烟酒嗜好、职业、文化程度、婚姻状况、家庭关系和医疗费用的支付方式(即是否有医疗保险)等方面以及二组间合并高血压和糖尿病的患者数差异均无统计学意义。与对照组相比,治疗组射频导管消融术前的患者躯体化(1.38±0.40比1.65±0.56,P〈0.01)、焦虑(1.50±0.39比1.69±0.50,P〈0.05)、恐怖(1.24±0.36比1.47±0.57,P〈0.01)、精神病性(1.24±0.34比1.35±0.30,P〈0.05)和总均分(1.36±0.35比1.49±0.37,P〈0.05)等项目评分均有明显下降,治疗组住院费用(32498±1170)元,明显低于对照组(32947±1096)元,P〈0.05。结论术前服用阿普唑仑可改善射频导管消融手术患者的心理状况并降低其住院费用。

关 键 词:阿普唑仑 导管消融术 费用节省 心理测定学
修稿时间:2007-02-16

Alprazolam use improves psychological status and reduces hospitalization costs in patients with paroxysmal supraventricular tachycardia underwent radiofrequency catheter ablation
Zhu Yu-juan,Liu Zi-yan,Chen Yao,Zheng Ping,Zhu Jian-hua,Tao Qian-min,Zheng Liang-rong,Wang Qi-qi,Shi Ming-juan,Qiu Yuan-gang. Alprazolam use improves psychological status and reduces hospitalization costs in patients with paroxysmal supraventricular tachycardia underwent radiofrequency catheter ablation[J]. Chinese Journal of Cardiology, 2007, 35(10): 919-922
Authors:Zhu Yu-juan  Liu Zi-yan  Chen Yao  Zheng Ping  Zhu Jian-hua  Tao Qian-min  Zheng Liang-rong  Wang Qi-qi  Shi Ming-juan  Qiu Yuan-gang
Affiliation:Department of Cardiology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou 310003, China
Abstract:OBJECTIVE: To evaluate the effect of alprazolam use on psychological status and hospitalization cost in patient with paroxysmal supraventricular tachycardia underwent electrophysiology studies or radiofrequency catheter ablation. METHODS: In this prospective, randomized, double-blind, placebo-controlled study, 142 inpatients [77 males, mean age (43.1 +/- 14.5) years] were randomly assigned to receive alprazolam (0.4 mg qd at 10PM for 3 days, n = 72) or placebo (n = 70) 3 days before scheduled electrophysiology studies or radiofrequency catheter ablation. All patients were examined by the Chinese version of Symptom Checklist-90 (SCL-90) at 24 hours before the procedure. RESULTS: Compared with the placebo group, the scores of somatization (1.38 +/- 0.40 vs. 1.65 +/- 0.56, P < 0.01), anxiety (1.50 +/- 0.39 vs. 1.69 +/- 0.50, P < 0.05), phobic anxiety (1.24 +/- 0.36 vs. 1.47 +/- 0.57, P < 0.01), psychotism constructs (1.24 +/- 0.34 vs. 1.35 +/- 0.30, P < 0.05) and global severity index (1.36 +/- 0.35 vs. 1.49 +/- 0.37, P < 0.05) were significantly decreased in alprazolam group. The hospitalization costs were also significantly lower in alprazolam group (32 498 +/- 1170) yuan compared to placebo group (32 947 +/- 1096) yuan, P < 0.05. CONCLUSION: The alprazolam use before electrophysiology studies and radiofrequency catheter ablation can improve the patients' psychological status and reduce the hospitalization costs.
Keywords:Alprazolam   Catheter ablation    Cost savings    Psychometrics
本文献已被 维普 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号